Radiotherapy for non-small cell lung cancer

Lung Cancer

Volumn 34, Issue SUPPL. 2, 2001, Pages

  Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

NSCLC; Radiotherapy

Indexed keywords

CARBOGEN; NICOTINAMIDE; TIRAPAZAMINE;

BEAM THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; LUNG NON SMALL CELL CANCER; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0035200314     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00365-8     Document Type: Conference Paper

References (28)

1. Lung cancer
2. The survival of patients with inoperable lung cancer: A large scale randomised study of radiation therapy versus placebo
3. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer
4. Radiotherapie du cancer bronchique non a petites cellules de stade III, inoperable, asymptomatique. Results definitifs d'un essai prospectif randomise (240 patients)
5. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung
6. Long-term observations of the pattern of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy
7. The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: An RTOG analysis
8. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?
9. The rationale and use of three-dimensional radiation treatment planning for lung cancer
10. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy
11. Role of positron emission tomography in the staging of lung cancer
12. Intensity modulated radiation therapy: A clinical review
13. Held-breath self-gating technique for radiotherapy of non-small cell lung cancer: A feasibility study
14. RTOG 88-08, ECOG 4588, preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer
15. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial
16. ARCON: Accelerated radiotherapy with carbogen and nicotinamine in non-small cell lung cancer: A phase I/II study by the EORTC
17. Tirapazamine: A bioreductive anticancer drug exploits tumor hypoxia
18. The potential role of amifostine in the treatment of non-small cell lung cancer
19. Pre-operative radiotherapy in the treatment of bronchial carcinoma
20. Preoperative irradiation of cancer of the lung: Final report of a therapeutic trial. A collaborative study
21. Results of a controlled clinical trial for evaluation of intensive preoperative irradiation in operable bronchial cancer
22. Preoperative concurrent chemoradiotherapy for unresectable stage III nonsmall cell lung cancer
23. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials
24. Palliative radiotherapy for inoperable carcinoma of the lung: Final report of a RTOG multi-instutional trial
25. A randomized study on palliative radiation therapy for inoperable non-small cell carcinoma of the lung
26. Inoperable non-small-cell lung cancer (NSCLC): A Medical Research Council randomized trial of palliative radiotherapy with two fractions or ten fractions
27. A Medical Research Council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status
28. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status